NOVAVAX INC - COM (NVAX)

CUSIP: 670002104

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
162,468,893
Share change
+7,053,191
Total reported value
$217,698,986
Put/Call ratio
152%
Price per share
$1.34
Number of holders
145
Value change
+$2,139,994
Number of buys
84
Number of sells
44

Quarterly Holders Quick Answers

What is CUSIP 670002104?
CUSIP 670002104 identifies NVAX - NOVAVAX INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVAVAX INC - COM (NVAX) as of Q2 2018

As of 30 Jun 2018, NOVAVAX INC - COM (NVAX) was held by 145 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 162,468,893 shares. The largest 10 holders included BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, BB BIOTECH AG, MORGAN STANLEY, FRANKLIN RESOURCES INC, JPMORGAN CHASE & CO, NORTHERN TRUST CORP, FMR LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 145 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.